References
- Balis FM, Blaney SM, McCully CL, Bacher JD, Murphy RF, Poplack DG : Methotrexate distribution within the subarachnoid space after intraventricular and intravenous administration. Cancer Chemother Pharmacol 45 : 259-264, 2000 https://doi.org/10.1007/s002800050038
- Baraniskin A, Kuhnhenn J, Schlegel U, Schmiegel W, Hahn S, Schroers R : MicroRNAs in cerebrospinal fluid as biomarker for disease course monitoring in primary central nervous system lymphoma. J Neurooncol 109 : 239-244, 2012 https://doi.org/10.1007/s11060-012-0908-2
- Bernardi RJ, Bomgaars L, Fox E, Balis FM, Egorin MJ, Lagattuta TF, et al. : Phase I clinical trial of intrathecal gemcitabine in patients with neoplastic meningitis. Cancer Chemother Pharmacol 62 : 355-361, 2008 https://doi.org/10.1007/s00280-007-0601-x
- Blaney SM, Balis FM, Berg S, Arndt CA, Heideman R, Geyer JR, et al. : Intrathecal mafosfamide : a preclinical pharmacology and phase I trial. J Clin Oncol 23 : 1555-1563, 2005 https://doi.org/10.1200/JCO.2005.06.053
- Blaney SM, Boyett J, Friedman H, Gajjar A, Geyer R, Horowtiz M, et al. : Phase I clinical trial of mafosfamide in infants and children aged 3 years or younger with newly diagnosed embryonal tumors : a pediatric brain tumor consortium study (PBTC-001). J Clin Oncol 23 : 525-531, 2005 https://doi.org/10.1200/JCO.2005.06.544
- Blaney SM, Cole DE, Balis FM, Godwin K, Poplack DG : Plasma and cerebrospinal fluid pharmacokinetic study of topotecan in nonhuman primates. Cancer Res 53 : 725-727, 1993
- Blaney SM, Heideman R, Berg S, Adamson P, Gillespie A, Geyer JR, et al. : Phase I clinical trial of intrathecal topotecan in patients with neoplastic meningitis. J Clin Oncol 21 : 143-147, 2003 https://doi.org/10.1200/JCO.2003.04.053
- Blaney SM, Kocak M, Gajjar A, Chintagumpala M, Merchant T, Kieran M, et al. : Pilot study of systemic and intrathecal mafosfamide followed by conformal radiation for infants with intracranial central nervous system tumors : a pediatric brain tumor consortium study (PBTC-001). J Neurooncol 109 : 565-571, 2012 https://doi.org/10.1007/s11060-012-0929-x
- Blaney SM, Poplack DG : New cytotoxic drugs for intrathecal administration. J Neurooncol 38 : 219-223, 1998 https://doi.org/10.1023/A:1005944622003
- Blasberg RG, Patlak CS, Shapiro WR : Distribution of methotrexate in the cerebrospinal fluid and brain after intraventricular administration. Cancer Treat Rep 61 : 633-641, 1977
- Bokstein F, Lossos A, Lossos IS, Siegal T : Central nervous system relapse of systemic non-Hodgkin's lymphoma : results of treatment based on high-dose methotrexate combination chemotherapy. Leuk Lymphoma 43 : 587-593, 2002 https://doi.org/10.1080/10428190290012092
- Bokstein F, Lossos A, Siegal T : Leptomeningeal metastases from solid tumors : a comparison of two prospective series treated with and without intra-cerebrospinal fluid chemotherapy. Cancer 82 : 1756-1763, 1998 https://doi.org/10.1002/(SICI)1097-0142(19980501)82:9<1764::AID-CNCR24>3.0.CO;2-1
- Boogerd W, van den Bent MJ, Koehler PJ, Heimans JJ, van der Sande JJ, Aaronson NK, et al. : The relevance of intraventricular chemotherapy for leptomeningeal metastasis in breast cancer : a randomised study. Eur J Cancer 40 : 2726-2733, 2004 https://doi.org/10.1016/j.ejca.2004.08.012
- Bruna J, Gonzalez L, Miro J, Velasco R, Gil M, Tortosa A, et al. : Leptomeningeal carcinomatosis : prognostic implications of clinical and cerebrospinal fluid features. Cancer 115 : 381-389, 2009 https://doi.org/10.1002/cncr.24041
- Chamberlain MC : Leptomeningeal metastases : a review of evaluation and treatment. J Neurooncol 37 : 271-284, 1998 https://doi.org/10.1023/A:1005976926058
- Chamberlain MC : Radioisotope CSF flow studies in leptomeningeal metastases. J Neurooncol 38 : 135-140, 1998 https://doi.org/10.1023/A:1005982826121
- Chamberlain MC, Kormanik P : Carcinoma meningitis secondary to non-small cell lung cancer : combined modality therapy. Arch Neurol 55 : 506-512, 1998 https://doi.org/10.1001/archneur.55.4.506
- Chamberlain MC, Kormanik PA : Prognostic significance of 111indium-DTPA CSF flow studies in leptomeningeal metastases. Neurology 46 : 1674-1677, 1996 https://doi.org/10.1212/WNL.46.6.1674
- Chamberlain MC, Kormanik PA, Barba D : Complications associated with intraventricular chemotherapy in patients with leptomeningeal metastases. J Neurosurg 87 : 694-699, 1997 https://doi.org/10.3171/jns.1997.87.5.0694
- Clarke JL, Pao W, Wu N, Miller VA, Lassman AB : High dose weekly erlotinib achieves therapeutic concentrations in CSF and is effective in leptomeningeal metastases from epidermal growth factor receptor mutant lung cancer. J Neurooncol 99 : 283-286, 2010 https://doi.org/10.1007/s11060-010-0128-6
- de Azevedo CR, Cruz MR, Chinen LT, Peres SV, Peterlevitz MA, de Azevedo Pereira AE, et al. : Meningeal carcinomatosis in breast cancer : prognostic factors and outcome. J Neurooncol 104 : 565-572, 2011 https://doi.org/10.1007/s11060-010-0524-y
- Egorin MJ, Zuhowski EG, McCully CM, Blaney SM, Kerr JZ, Berg SL, et al. : Pharmacokinetics of intrathecal gemcitabine in nonhuman primates. Clin Cancer Res 8 : 2437-2442, 2002
- Fizazi K, Asselain B, Vincent-Salomon A, Jouve M, Dieras V, Palangie T, et al. : Meningeal carcinomatosis in patients with breast carcinoma. Clinical features, prognostic factors, and results of a high-dose intrathecal methotrexate regimen. Cancer 77 : 1315-1323, 1996 https://doi.org/10.1002/(SICI)1097-0142(19960401)77:7<1315::AID-CNCR14>3.0.CO;2-4
- Fleischhack G, Jaehde U, Bode U : Pharmacokinetics following intraventricular administration of chemotherapy in patients with neoplastic meningitis. Clin Pharmacokinet 44 : 1-31, 2005
- Freilich RJ, Krol G, DeAngelis LM : Neuroimaging and cerebrospinal fluid cytology in the diagnosis of leptomeningeal metastasis. Ann Neurol 38 : 51-57, 1995 https://doi.org/10.1002/ana.410380111
- Gauthier H, Guilhaume MN, Bidard FC, Pierga JY, Girre V, Cottu PH, et al. : Survival of breast cancer patients with meningeal carcinomatosis. Ann Oncol 21 : 2183-2187, 2010 https://doi.org/10.1093/annonc/mdq232
- Glantz MJ, Jaeckle KA, Chamberlain MC, Phuphanich S, Recht L, Swinnen LJ, et al. : A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors. Clin Cancer Res 5 : 3394-3402, 1999
- Glass JP, Melamed M, Chernik NL, Posner JB : Malignant cells in cerebrospinal fluid (CSF) : the meaning of a positive CSF cytology. Neurology 29 : 1369-1375, 1979 https://doi.org/10.1212/WNL.29.10.1369
- Gleissner B, Chamberlain MC : Neoplastic meningitis. Lancet Neurol 5 : 443-452, 2006 https://doi.org/10.1016/S1474-4422(06)70443-4
- Grossman SA, Krabak MJ : Leptomeningeal carcinomatosis. Cancer Treat Rev 25 : 103-119, 1999 https://doi.org/10.1053/ctrv.1999.0119
- Grossman SA, Reinhard CS, Loats HL : The intracerebral penetration of intraventricularly administered methotrexate : a quantitative autoradiographic study. J Neurooncol 7 : 319-328, 1989 https://doi.org/10.1007/BF02147089
- Grossman SA, Trump DL, Chen DC, Thompson G, Camargo EE : Cerebrospinal fluid flow abnormalities in patients with neoplastic meningitis. An evaluation using 111indium-DTPA ventriculography. Am J Med 73 : 641-647, 1982 https://doi.org/10.1016/0002-9343(82)90404-1
- Gururangan S, Petros WP, Poussaint TY, Hancock ML, Phillips PC, Friedman HS, et al. : Phase I trial of intrathecal spartaject busulfan in children with neoplastic meningitis : a Pediatric Brain Tumor Consortium Study (PBTC-004). Clin Cancer Res 12 : 1540-1546, 2006 https://doi.org/10.1158/1078-0432.CCR-05-2094
- Gwak HS, Joo J, Kim S, Yoo H, Shin SH, Han JY, et al. : Analysis of treatment outcomes of intraventricular chemotherapy in 105 patients for leptomeningeal carcinomatosis from non-small-cell lung cancer. J Thorac Oncol 8 : 599-605, 2013 https://doi.org/10.1097/JTO.0b013e318287c943
- Gwak HS, Joo J, Shin SH, Yoo H, Han JY, Kim HT, et al. : Ventriculolumbar perfusion chemotherapy with methotrexate for treating leptomeningeal carcinomatosis : a Phase II Study. Oncologist 19 : 1044-1045, 2014 https://doi.org/10.1634/theoncologist.2014-0199
- Gwak HS, Lim HS, Shin SH, Yoo H, Han JY, Kim HT, et al. : Ventriculolumbar perfusion chemotherapy for the treatment of leptomeningeal carcinomatosis : a phase I study with pharmacokinetic data. Am J Clin Oncol 36 : 491-499, 2013 https://doi.org/10.1097/COC.0b013e3182549643
- Herrlinger U, Forschler H, Kuker W, Meyermann R, Bamberg M, Dichgans J, et al. : Leptomeningeal metastasis : survival and prognostic factors in 155 patients. J Neurol Sci 223 : 167-178, 2004 https://doi.org/10.1016/j.jns.2004.05.008
- Hitchins RN, Bell DR, Woods RL, Levi JA : A prospective randomized trial of single-agent versus combination chemotherapy in meningeal carcinomatosis. J Clin Oncol 5 : 1655-1662, 1987 https://doi.org/10.1200/JCO.1987.5.10.1655
- Hofer S, Mengele K, Stemmler HJ, Schmitt M, Pestalozzi B : Intrathecal trastuzumab : dose matters. Acta Oncol 51 : 955-956, 2012 https://doi.org/10.3109/0284186X.2012.673736
- Katayama T, Shimizu J, Suda K, Onozato R, Fukui T, Ito S, et al. : Efficacy of erlotinib for brain and leptomeningeal metastases in patients with lung adenocarcinoma who showed initial good response to gefitinib. J Thorac Oncol 4 : 1415-1419, 2009 https://doi.org/10.1097/JTO.0b013e3181b62572
- Kim DY, Lee KW, Yun T, Park SR, Jung JY, Kim DW, et al. : Comparison of intrathecal chemotherapy for leptomeningeal carcinomatosis of a solid tumor : methotrexate alone versus methotrexate in combination with cytosine arabinoside and hydrocortisone. Jpn J Clin Oncol 33 : 608-612, 2003 https://doi.org/10.1093/jjco/hyg118
- Laufman LR, Forsthoefel KF : Use of intrathecal trastuzumab in a patient with carcinomatous meningitis. Clin Breast Cancer 2 : 235, 2001 https://doi.org/10.1016/S1526-8209(11)70419-0
- Levin VA, Byrd D, Campbell J, Giannini DD, Borcich JK, Davis RL : Central nervous system toxicity and cerebrospinal fluid pharmacokinetics of intraventricular 3-[(4-amino-2-methyl-5-pyrimidinyl)ethyl]-1-(2-chloroethyl)-1-nitro soureas and other nitrosoureas in beagles. Cancer Res 45 : 3803-3809, 1985
- Levin VA, Chamberlain M, Silver P, Rodriguez L, Prados M : Phase I/II study of intraventricular and intrathecal ACNU for leptomeningeal neoplasia. Cancer Chemother Pharmacol 23 : 301-307, 1989 https://doi.org/10.1007/BF00292408
- Liu S, Sun J, Lan Q : Glioblastoma microvesicles promote endothelial cell proliferation through Akt/beta-catenin pathway. Int J Clin Exp Pathol 7 : 4857-4866, 2014
- Masuda T, Hattori N, Hamada A, Iwamoto H, Ohshimo S, Kanehara M, et al. : Erlotinib efficacy and cerebrospinal fluid concentration in patients with lung adenocarcinoma developing leptomeningeal metastases during gefitinib therapy. Cancer Chemother Pharmacol 67 : 1465-1469, 2011 https://doi.org/10.1007/s00280-011-1555-6
- Mittl RL Jr, Yousem DM : Frequency of unexplained meningeal enhancement in the brain after lumbar puncture. AJNR Am J Neuroradiol 15 : 633-638, 1994
- Morris PG, Reiner AS, Szenberg OR, Clarke JL, Panageas KS, Perez HR, et al. : Leptomeningeal metastasis from non-small cell lung cancer : survival and the impact of whole brain radiotherapy. J Thorac Oncol 7 : 382-385, 2012 https://doi.org/10.1097/JTO.0b013e3182398e4f
- Nakagawa H, Fujita T, Kubo S, Izumoto S, Nakajima Y, Tsuruzono K, et al. : Ventriculolumbar perfusion chemotherapy with methotrexate and cytosine arabinoside for meningeal carcinomatosis : a pilot study in 13 patients. Surg Neurol 45 : 256-264, 1996 https://doi.org/10.1016/0090-3019(95)00403-3
- Ongerboer de Visser BW, Somers R, Nooyen WH, van Heerde P, Hart AA, McVie JG : Intraventricular methotrexate therapy of leptomeningeal metastasis from breast carcinoma. Neurology 33 : 1565-1572, 1983 https://doi.org/10.1212/WNL.33.12.1565
- Park JH, Kim YJ, Lee JO, Lee KW, Kim JH, Bang SM, et al. : Clinical outcomes of leptomeningeal metastasis in patients with non-small cell lung cancer in the modern chemotherapy era. Lung Cancer 76 : 387-392, 2012 https://doi.org/10.1016/j.lungcan.2011.11.022
- Rubin RC, Ommaya AK, Henderson ES, Bering EA, Rall DP : Cerebrospinal fluid perfusion for central nervous system neoplasms. Neurology 16 : 680-692, 1966 https://doi.org/10.1212/WNL.16.7.680
- Sato Y, Ohta Y, Kaji M, Oizumi K, Kaji M : Carbohydrate antigen 19-9 in cerebrospinal fluid and within malignant cells in a case of leptomeningeal carcinomatosis. J Neurol Neurosurg Psychiatry 65 : 402-403, 1998 https://doi.org/10.1136/jnnp.65.3.402
- Schabet M, Kloeter I, Adam T, Heidemann E, Wietholter H : Diagnosis and treatment of meningeal carcinomatosis in ten patients with breast cancer. Eur Neurol 25 : 403-411, 1986 https://doi.org/10.1159/000116043
- Shapiro WR, Young DF, Mehta BM : Methotrexate : distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injections. N Engl J Med 293 : 161-166, 1975 https://doi.org/10.1056/NEJM197507242930402
- Siegal T, Lossos A, Pfeffer MR : Leptomeningeal metastases : analysis of 31 patients with sustained off-therapy response following combined-modality therapy. Neurology 44 : 1463-1469, 1994 https://doi.org/10.1212/WNL.44.8.1463
- Straathof CS, de Bruin HG, Dippel DW, Vecht CJ : The diagnostic accuracy of magnetic resonance imaging and cerebrospinal fluid cytology in leptomeningeal metastasis. J Neurol 246 : 810-814, 1999 https://doi.org/10.1007/s004150050459
- Swinkels DW, de Kok JB, Hanselaar A, Lamers K, Boerman RH : Early detection of leptomeningeal metastasis by PCR examination of tumor-derived K-ras DNA in cerebrospinal fluid. Clin Chem 46 : 132-133, 2000
- Taillibert S, Laigle-Donadey F, Chodkiewicz C, Sanson M, Hoang-Xuan K, Delattre JY : Leptomeningeal metastases from solid malignancy : a review. J Neurooncol 75 : 85-99, 2005 https://doi.org/10.1007/s11060-004-8101-x
- Teplyuk NM, Mollenhauer B, Gabriely G, Giese A, Kim E, Smolsky M, et al. : MicroRNAs in cerebrospinal fluid identify glioblastoma and metastatic brain cancers and reflect disease activity. Neuro Oncol 14 : 689-700, 2012 https://doi.org/10.1093/neuonc/nos074
- Tetef ML, Margolin KA, Doroshow JH, Akman S, Leong LA, Morgan RJ Jr, et al. : Pharmacokinetics and toxicity of high-dose intravenous methotrexate in the treatment of leptomeningeal carcinomatosis. Cancer Chemother Pharmacol 46 : 19-26, 2000 https://doi.org/10.1007/s002800000118
- Tran HC, Gardner S, Weiner HL, Liebes LF, Finlay JL : Pilot study assessing a seven-day continuous intrathecal topotecan infusion for recurrent or progressive leptomeningeal metastatic cancer. J Oncol Pharm Pract 20 : 229-232, 2014 https://doi.org/10.1177/1078155213494940
- Twijnstra A, van Zanten AP, Hart AA, Ongerboer de Visser BW : Serial lumbar and ventricle cerebrospinal fluid lactate dehydrogenase activities in patients with leptomeningeal metastases from solid and haematological tumours. J Neurol Neurosurg Psychiatry 50 : 313-320, 1987 https://doi.org/10.1136/jnnp.50.3.313
- Twijnstra A, van Zanten AP, Nooyen WJ, Ongerboer de Visser BW : Sensitivity and specificity of single and combined tumour markers in the diagnosis of leptomeningeal metastasis from breast cancer. J Neurol Neurosurg Psychiatry 49 : 1246-1250, 1986 https://doi.org/10.1136/jnnp.49.11.1246
- Waki F, Ando M, Takashima A, Yonemori K, Nokihara H, Miyake M, et al. : Prognostic factors and clinical outcomes in patients with leptomeningeal metastasis from solid tumors. J Neurooncol 93 : 205-212, 2009 https://doi.org/10.1007/s11060-008-9758-3
- Wasserstrom WR, Glass JP, Posner JB : Diagnosis and treatment of leptomeningeal metastases from solid tumors : experience with 90 patients. Cancer 49 : 759-772, 1982 https://doi.org/10.1002/1097-0142(19820215)49:4<759::AID-CNCR2820490427>3.0.CO;2-7
- Yi HG, Kim HJ, Kim YJ, Han SW, Oh DY, Lee SH, et al. : Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are effective for leptomeningeal metastasis from non-small cell lung cancer patients with sensitive EGFR mutation or other predictive factors of good response for EGFR TKI. Lung Cancer 65 : 80-84, 2009 https://doi.org/10.1016/j.lungcan.2008.10.016
- Yousem DM, Patrone PM, Grossman RI : Leptomeningeal metastases : MR evaluation. J Comput Assist Tomogr 14 : 255-261, 1990 https://doi.org/10.1097/00004728-199003000-00018
- Zagouri F, Sergentanis TN, Bartsch R, Berghoff AS, Chrysikos D, de Azambuja E, et al. : Intrathecal administration of trastuzumab for the treatment of meningeal carcinomatosis in HER2-positive metastatic breast cancer : a systematic review and pooled analysis. Breast Cancer Res Treat 139 : 13-22, 2013 https://doi.org/10.1007/s10549-013-2525-y
Cited by
- Chronic Meningitis: Simplifying a Diagnostic Challenge vol.16, pp.3, 2015, https://doi.org/10.1007/s11910-016-0630-0
- 甲氨蝶呤鞘内注射治疗脑膜癌病疗效和安全性的临床观察 vol.19, pp.5, 2015, https://doi.org/10.3779/j.issn.1009-3419.2016.05.08
- A rare case of leptomeningeal carcinomatosis in a patient with uveal melanoma: case report and review of literature vol.26, pp.5, 2015, https://doi.org/10.1097/cmr.0000000000000274
- CAN a P-gp modulator assist in the control of methotrexate concentrations in the rat brain? −inhibitory effects of rhodamine 123, a specific substrate for P-gp, on methotrexate excretion from t vol.79, pp.2, 2015, https://doi.org/10.1292/jvms.16-0315
- Novel Anterior Brainstem Magnetic Resonance Imaging Findings in Non-Small Cell Lung Cancer with Leptomeningeal Carcinomatosis vol.8, pp.None, 2017, https://doi.org/10.3389/fneur.2017.00579
- Surgical Treatment for Leptomeningeal Disease vol.24, pp.1, 2015, https://doi.org/10.1177/107327481702400107
- Management and survival of patients with leptomeningeal disease from breast cancer: a case series vol.6, pp.1, 2015, https://doi.org/10.2217/bmt-2017-0004
- Diagnostic and prognostic values of cerebrospinal fluid CYFRA 21-1 in patients with leptomeningeal carcinomatosis vol.8, pp.32, 2017, https://doi.org/10.18632/oncotarget.18405
- Intracranial Leptomeningeal Carcinomatosis: A Diagnostic Study with 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography vol.10, pp.1, 2015, https://doi.org/10.1159/000486710
- Choroid Plexus Carcinoma in Adults: Two Case Reports vol.7, pp.1, 2015, https://doi.org/10.14791/btrt.2019.7.e23
- Association of MRI findings with clinical characteristics and prognosis in patients with leptomeningeal carcinomatosis from non-small cell lung cancer vol.143, pp.3, 2015, https://doi.org/10.1007/s11060-019-03190-3
- Fate of nanoparticles in the central nervous system after intrathecal injection in healthy mice vol.9, pp.1, 2019, https://doi.org/10.1038/s41598-019-49028-w
- Clinical outcome of cerebrospinal fluid shunts in patients with leptomeningeal carcinomatosis vol.17, pp.None, 2015, https://doi.org/10.1186/s12957-019-1595-7
- CYFRA 21-1 levels in cerebrospinal fluid as a putative therapeutic monitoring biomarker for patients with leptomeningeal carcinomatosis: A pilot study vol.28, pp.1, 2015, https://doi.org/10.3233/cbm-190187
- Exploratory Profiling of Extracellular MicroRNAs in Cerebrospinal Fluid Comparing Leptomeningeal Metastasis with Other Central Nervous System Tumor Statuses vol.10, pp.21, 2021, https://doi.org/10.3390/jcm10214860
- Clinical efficacy and safety of different doses of intrathecal methotrexate in the treatment of leptomeningeal carcinomatosis: a prospective and single-arm study vol.51, pp.12, 2015, https://doi.org/10.1093/jjco/hyab155